News

Published on 13 Mar 2024 on Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In...


Article preview image

Shares of Clover Health Investments, Corp. CLOV rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year.

NASDAQ.SMMT price evolution
NASDAQ.SIGA price evolution
NASDAQ.CLOV price evolution
NYSE.PBF price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therap...

Insider Monkey via Yahoo Finance 2 May 2024

Summit Therapeutics appoints genomics expert to board

Summit Therapeutics Inc. ( NASDAQ : NASDAQ: SMMT ) announced the immediate appointment of Mostafa...

Investing.com 11 Apr 2024

Illumina announces new executive team members By Investing.com

Dhingra, with a career spanning over 18 years at Agilent Technologies (NYSE:A) and former CFO rol...

Investing.com 10 Apr 2024

Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) toda...

Investing.com 10 Apr 2024

Illumina Reveals Departure of Joydeep Goswami, Appoints Former Summit Therapeutics Executive as New...

Illumina, Inc., a San Diego, California-headquartered biotechnology firm, announced that its chie...

EconoTimes 10 Apr 2024

Q1 Earnings Season Poised to Fuel Stock Rally? | Investing.com

Market Overview Analysis by Christine Short covering: S&P 500, Microsoft Corporation, McDonald’s...

Investing.com 4 Apr 2024

Summit Materials (NYSE:SUM) Price Target Increased to $53.00 by Analysts at Truist Financial

Summit Materials (NYSE:SUM – Get Free Report) had its price target hoisted by equities researcher...

ETF DAILY NEWS 4 Apr 2024

Trevi Therapeutics to Participate in Upcoming April Events By Investing.com

Trevi Therapeutics to Participate in Upcoming April Events

Investing.com 4 Apr 2024

Insiders Are Buying These 11 Penny Stocks

In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a...

Insider Monkey via Yahoo Finance 2 Apr 2024

Summit Therapeutics CFO Ankur Dhingra steps down

Summit Therapeutics CFO Ankur Dhingra steps down

Investing.com 2 Apr 2024